• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzylamines 2-benzylaminopyridines

Introduction to 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine (CAS No. 1033202-35-5)

5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine, a compound with the chemical identifier CAS No. 1033202-35-5, represents a significant advancement in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its intricate molecular structure, has garnered considerable attention due to its potential applications in drug discovery and development. The presence of multiple functional groups, including a bromine substituent, a nitro group, and an amine moiety, makes it a versatile scaffold for synthesizing novel bioactive molecules.

The 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine molecule is derived from pyridine, a heterocyclic aromatic compound that serves as a fundamental building block in organic synthesis. The pyridine core is particularly valuable in medicinal chemistry due to its ability to interact with biological targets such as enzymes and receptors. The introduction of bromine at the 5-position and a nitro group at the 3-position enhances the electrophilic nature of the molecule, making it more reactive in various chemical transformations. Additionally, the N-(4-methoxybenzyl) substituent adds another layer of complexity, influencing both the electronic properties and solubility characteristics of the compound.

In recent years, there has been a surge in research focused on developing small molecules that can modulate biological pathways associated with diseases such as cancer, inflammation, and neurodegeneration. The 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine has emerged as a promising candidate in this context due to its structural features that allow for selective binding to specific biological targets. For instance, studies have shown that this compound can interact with kinases and other enzymes involved in cell signaling pathways. The bromine atom, in particular, has been identified as a key moiety for facilitating interactions with certain protein residues, enhancing binding affinity.

The pharmaceutical industry has been increasingly leveraging computational methods and high-throughput screening techniques to identify novel drug candidates. The 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine has been subjected to rigorous computational modeling to predict its binding interactions with target proteins. These studies have revealed that the compound can potentially inhibit the activity of several kinases, which are overexpressed in various cancers. The nitro group at the 3-position of the pyridine ring has been found to play a crucial role in stabilizing the transition state during enzyme inhibition, making it an effective pharmacophore.

Beyond its applications in oncology, the 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine has also shown promise in treating inflammatory diseases. Research indicates that this compound can modulate inflammatory pathways by inhibiting key enzymes such as COX-2 and LOX. The methoxy group on the benzyl moiety contributes to the compound's ability to cross the blood-brain barrier, which is essential for treating neurological disorders. This property makes it an attractive candidate for developing therapies targeting central nervous system disorders.

The synthesis of 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to ensure high yields and purity of the final product. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the complex pyridine scaffold. Additionally, green chemistry principles have been integrated into the synthesis process to minimize waste and reduce environmental impact.

In conclusion, the 5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine (CAS No. 1033202-35-5) represents a significant advancement in pharmaceutical chemistry with broad applications in drug discovery and development. Its unique structural features make it a versatile scaffold for synthesizing bioactive molecules targeting various diseases. Ongoing research continues to explore its potential applications and optimize synthetic methodologies for large-scale production. As our understanding of biological pathways grows, compounds like this are poised to play a crucial role in developing next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)